SCIRE' CARLO ALBERTO

Silvagni, E., Bortoluzzi, A., Occhino, G., Bellelli, G., Garaffoni, C., Delvino, P., et al. (2025). Frailty and cardiovascular safety of JAK inhibitors versus TNF inhibitors in rheumatoid arthritis: a real-world comparative study of drug effects and patient profiles. FRONTIERS IN PHARMACOLOGY, 16 [10.3389/fphar.2025.1565909]. Dettaglio

Rebora, P., Occhino, G., Bellelli, G., Leoni, O., Casazza, S., Valsecchi, M., et al. (2025). Population-based validation of a frailty index using electronic regional healthcare records for public health use. SCIENTIFIC REPORTS, 15(1) [10.1038/s41598-025-18611-9]. Dettaglio

Faghihi-Kashani, S., Yoshida, A., Bozan, F., Zanframundo, G., Rozza, D., Loganathan, A., et al. (2025). Clinical Characteristics of Anti-synthetase Syndrome: Analysis From the Classification Criteria for Anti-Synthetase Syndrome Project. ARTHRITIS & RHEUMATOLOGY, 77(4 (April 2025)), 477-489 [10.1002/art.43038]. Dettaglio

Sakellariou, G., Schiepatti, A., Zanetti, A., Montecucco, C., Biagi, F., Scire, C. (2025). Prevalence and incidence of celiac disease in patients with rheumatoid arthritis: a case-control study based on the RECORD cohort. FRONTIERS IN MEDICINE, 11 [10.3389/fmed.2024.1470855]. Dettaglio

Garaffoni, C., Tamussin, M., Calciolari, I., Lanza, G., Bortoluzzi, A., Scirè, C., et al. (2024). High-grade synovitis associates with clinical markers and response to therapy in chronic inflammatory arthritis: post hoc analysis of a synovial biomarkers prospective cohort study. FRONTIERS IN IMMUNOLOGY, 14 [10.3389/fimmu.2023.1298583]. Dettaglio